Based on our 2009 Industry Report Biosimilars: TNF-Alpha Inhibitors and Interferon-Alphas in Immune and Infectious Disease, Decision Resources is offering an exclusive webinar entitled Despite Physicians' Conservative Attitude Towards Biosimilars, TNF-Alpha Inhibitors Stand to Lose $22 Billion in Sales. Because this webinar features major report findings, it is ONLY available to purchasers of this report.
This webinar was held on December 3, 2009. Contact us to learn how you can purchase this report and access a recorded playback of this event.
Click here to view the invite.